Opportunity Information: Apply for CDC RFA DD10 1008
Apply for CDC RFA DD10 1008
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.073 Birth Defects and Developmental Disabilities Prevention and Surveillance.
- This funding opportunity was created on Apr 30, 2010 and posted on Apr 30, 2010.
- Applicants must submit their applications by Jun 14, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non US) entity A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers" (Funding Opportunity Number CDC RFA DD10 1008), is a Centers for Disease Control and Prevention (CDC) discretionary funding program offered through a cooperative agreement. Its central goal is to improve recognition and speed up diagnosis of alveolar capillary dysplasia (ACD), a rare and often life-threatening condition affecting newborns, by creating and distributing targeted awareness and educational materials to clinicians most likely to encounter these cases, specifically neonatologists and pediatric intensive care physicians. The project is aligned with the Healthy People 2010 priority area of Maternal, Infant and Child Health, reflecting a broader public health interest in improving early identification of serious conditions in infants and strengthening clinical responsiveness in neonatal and pediatric critical care settings.
The CDC anticipated making a single award under this announcement, with an estimated total funding amount of $200,000. The award ceiling is $200,000 and the award floor is $150,000, indicating the project was expected to be a relatively focused, time-bound effort rather than a large multi-site initiative. There was no cost sharing or matching requirement, which lowers the financial barrier to applying and allows applicants to propose a project primarily supported by federal funds. The program falls under CFDA 93.073, "Birth Defects and Developmental Disabilities Prevention and Surveillance," signaling that the work is positioned within CDC efforts related to rare conditions, developmental outcomes, and improved detection and surveillance practices.
Because the funding mechanism is a cooperative agreement rather than a standard grant, the CDC typically expects substantial involvement with the recipient during the project. In practical terms, this commonly means the awardee may coordinate with CDC staff on key deliverables, messaging accuracy, dissemination plans, or evaluation approaches, especially when the outputs are public-facing health communication materials aimed at clinical decision-making and awareness.
Eligibility for the opportunity was broad and included a wide range of organizations that could plausibly produce and disseminate provider-facing educational resources. Eligible applicants included nonprofits (both with and without 501(c)(3) status, excluding institutions of higher education in those specific nonprofit categories), for-profit organizations (other than small businesses), small/minority/women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal organizations (including Alaska Native health corporations, Urban Indian health organizations, and tribal epidemiology centers), and state and local governments along with their bona fide agents. The announcement also permitted non-U.S. entities to apply. For applicants submitting as a bona fide agent on behalf of a state or local government, documentation was required in the form of a letter confirming that status, to be included with the application materials submitted through Grants.gov.
The timeline for the opportunity shows it was posted and created on April 30, 2010, with an original and current closing date of June 14, 2010, and an archive date of July 14, 2010. These dates indicate a standard, relatively short federal application window, consistent with a single-award communications and awareness project intended to be implemented promptly.
Overall, the opportunity was designed to produce practical awareness tools and distribute them directly to specialized frontline providers in neonatal and pediatric intensive care. The intended public health outcome is earlier suspicion and faster diagnosis of ACD in clinical settings where critically ill newborns are evaluated, which can reduce diagnostic delays and improve decision-making for care teams and families. For administrative or access questions, the CDC Procurement and Grants Office was the listed contact point, with phone support and an email address provided (770-488-2700; pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DD10 1008.
Which federal agency is offering this opportunity?
This is a Centers for Disease Control and Prevention (CDC) discretionary funding opportunity.
What type of funding mechanism is used?
The program is offered through a cooperative agreement, not a standard grant.
What does it mean that this is a cooperative agreement?
Because it is a cooperative agreement, CDC typically expects substantial involvement with the recipient during the project. This commonly includes coordination with CDC staff on items such as deliverables, accuracy of messaging, dissemination plans, and/or evaluation approaches, particularly because the outputs are public-facing educational and awareness materials intended for clinicians.
What is the main goal of the project?
The central goal is to improve recognition of alveolar capillary dysplasia (ACD) and speed up diagnosis by creating and distributing targeted awareness and educational materials to health care providers most likely to encounter ACD cases.
Who is the primary intended audience for the educational and awareness materials?
The materials are intended for clinicians most likely to encounter ACD in practice, specifically neonatologists and pediatric intensive care physicians.
What health condition is the focus of the project?
The focus is alveolar capillary dysplasia (ACD), described in the announcement as a rare and often life-threatening condition affecting newborns.
How does this opportunity connect to broader public health priorities?
The project aligns with the Healthy People 2010 priority area of Maternal, Infant and Child Health, reflecting an interest in improving early identification of serious infant conditions and strengthening clinical responsiveness in neonatal and pediatric critical care settings.
What CFDA number applies to this program?
The opportunity is listed under CFDA 93.073, "Birth Defects and Developmental Disabilities Prevention and Surveillance."
How much funding was available?
CDC anticipated an estimated total funding amount of $200,000 for this announcement.
How many awards did CDC expect to make?
CDC anticipated making a single award under this announcement.
What are the award floor and award ceiling?
The award ceiling is $200,000 and the award floor is $150,000.
Is cost sharing or matching required?
No. The announcement states there was no cost sharing or matching requirement.
What kinds of activities or deliverables were expected?
Based on the announcement description, the project was designed to produce practical awareness and educational tools and distribute them directly to specialized frontline providers in neonatal and pediatric intensive care (with emphasis on neonatologists and pediatric intensive care physicians).
What public health outcome was CDC aiming for?
The intended outcome was earlier suspicion and faster diagnosis of ACD in clinical settings where critically ill newborns are evaluated, reducing diagnostic delays and improving decision-making for care teams and families.
Who was eligible to apply?
Eligibility was broad. Eligible applicants included: nonprofits (both with and without 501(c)(3) status, excluding institutions of higher education in those specific nonprofit categories), for-profit organizations (other than small businesses), small/minority/women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal organizations (including Alaska Native health corporations, Urban Indian health organizations, and tribal epidemiology centers), and state and local governments along with their bona fide agents.
Were non-U.S. entities allowed to apply?
Yes. The announcement permitted non-U.S. entities to apply.
What is a "bona fide agent" and what documentation was required?
The opportunity allowed state and local governments to apply through bona fide agents. Applicants submitting as a bona fide agent were required to include documentation in the form of a letter confirming that status, submitted with the application materials through Grants.gov.
When was the opportunity posted?
The opportunity was posted/created on April 30, 2010.
What was the application closing date?
The original and current closing date listed was June 14, 2010.
When was the opportunity archived?
The archive date was July 14, 2010.
What do the dates suggest about the application window?
The dates indicate a relatively short federal application window, consistent with a single-award awareness/communications project intended to be implemented promptly.
Who should be contacted for administrative or access questions?
The listed contact point was the CDC Procurement and Grants Office.
What contact information was provided?
Phone: 770-488-2700
Email: pgotim@cdc.gov
Browse more opportunities from the same category: Health
Next opportunity: Homeland Security Preparedness Technical Assistance EMAP
Previous opportunity: Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology (T32)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD10 1008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD10 1008) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pathogens (R01) Apply for RFA AI 10 010 Funding Number: RFA AI 10 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Innovative Strategies for Serving Children and Youth with Epilepsy (Project Access) Apply for HRSA 10 100 Funding Number: HRSA 10 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Areas (SAC AA) Apply for HRSA 10 223 Funding Number: HRSA 10 223 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| American Red Cross, San Juan Puerto Rico Apply for CDC RFA CK 10 006E Funding Number: CDC RFA CK 10 006E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Asthma and Indoor and Outdoor Air Quality Education Program Apply for CDC RFA EH10 1007 Funding Number: CDC RFA EH10 1007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| Teenage Pregnancy Prevention Integrating Services, Programs, and Strategies through Community wide Initiatives Apply for CDC RFA DP10 1009 Funding Number: CDC RFA DP10 1009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 10 185 Funding Number: PAR 10 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 10 186 Funding Number: PAR 10 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 10 184 Funding Number: PAR 10 184 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program Project on Alcohol Related Research (P01) Apply for PAR 10 187 Funding Number: PAR 10 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tribal Tobacco Control Programs to Reduce Commercial Tobacco Use Among American Indians and Alaska Natives Apply for CDC RFA DP10 1002 Funding Number: CDC RFA DP10 1002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $340,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 10 151 Funding Number: HRSA 10 151 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| First Time Motherhood/New Parents Initiative Apply for HRSA 10 035 Funding Number: HRSA 10 035 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Telehealth Network Grant Program Apply for HRSA 10 213 Funding Number: HRSA 10 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| MCH Research Network Programs Apply for HRSA 10 163 Funding Number: HRSA 10 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Funded Community Health Centers and Title X Programs Apply for CDC RFA DD10 1006 Funding Number: CDC RFA DD10 1006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| Occupational Safety and Health Research (R01) Apply for PAR 10 188 Funding Number: PAR 10 188 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Training Center Apply for HRSA 10 270 Funding Number: HRSA 10 270 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Multi Component Youth/Young Adult Alcohol Prevention Trials (R01) Apply for RFA AA 11 001 Funding Number: RFA AA 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Integrated Health Project (IHP) Apply for RFA OAA 10 000006 Funding Number: RFA OAA 10 000006 Agency: Agency for International Development Category: Health Funding Amount: $142,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD10 1008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.